NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MaxWell Biomedical

MaxWell Biomedical

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.maxwellbiomedical.com/

Last Round

Grant

Sep 15, 2022

Total Funding Raised

$2.3M

Company Overview

MaxWell Biomedical is a medical technology company developing a device-based solution, Spatial Resynchronization Therapy (SRT), for atrial fibrillation (AFib) and heart failure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Telemedicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

atrial fibrillationAFibimplantable devicespatial resynchronization therapycardiac rhythm managementmedtechnon-destructive therapyAI medical deviceheart failure with preserved ejection fractionHFpEFremote patient monitoringRPMlow-energy cardiac pacingclosed-loop pacingelectrophysiologyclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MaxWell Biomedical Comparables

Compare MaxWell Biomedical with similar companies based on industry and business-model similarity.

MaxWell Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AtaCor Medical
74%
Medtronic
71%
Kobara Medical, Inc.
69%

MaxWell Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 15, 2022
AngelAug 4, 2020

Key People

Founding team and executive leadership

Randy Werneth

Chief Executive Officer

Executive Team

MaxWell Biomedical Investors

Notable investors and investment history

MaxWell Biomedical investors
InvestorRounds
SeedFolioAngel
National Heart, Lung, and Blood InstituteGrant
TCA Venture GroupAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors grew 140% MoM, reaching 1K.

MaxWell Biomedical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MaxWell Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MaxWell Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range13
Year Founded2019
Last FundingSep 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.